Plexon Inc Launches the New Optogenetic Stimulation System at Neuroscience 2011

Plexon Inc Launches the New Optogenetic Stimulation System at Neuroscience 2011

ID: 86327

(firmenpresse) - DALLAS, TX -- (Marketwire) -- 11/10/11 -- Plexon Inc, the leader in advanced, turnkey hardware and software for neurotechnology research, announces the expansion of its neuroscience research equipment into the optogenetic space with the Plexon Optogenetic Stimulation System at Neuroscience 2011. Optogenetics is a method of perturbing neural cells with specific wavelengths of light. By using a special type of gene therapy coupled with the optogenetic approach, brain researchers are able to turn certain cells on or off with a high level of specificity.

As researchers identify more applications for the innovative optogenetic techniques pioneered by labs at the Massachusetts Institute of Technology and Stanford University, they require capable commercial partners to develop the intricate systems and components. Harvey W. Wiggins, President and Founder of Plexon, commented on the new product line saying, "Plexon is always looking for ways to provide researchers with the most advanced and reliable techniques. We are excited to see not only what comes of this new product, but what advances the world will experience as a result of the researchers who utilize it."

Researchers will have the chance to check out the new Plexon Optogenetic Stimulation System, as well as the new DigiAmp™ 256 Digitizing Amplifier, at Neuroscience 2011 in booth #2309 guided by any one of the company's exceptionally experienced engineers, or maybe even by the founder himself.

About Plexon Inc
Plexon is the pioneering provider of innovative data acquisition systems for recording and analyzing signals from the brain and peripheral nervous system launching the first multi-channel data acquisition system more than 25 years ago. Backed by decades of experience, Plexon provides specialized tools for basic neurological research, brain-machine interfaces, neurodegenerative disease research, and neuroprosthetics for the growing neurotechnology industry. Its equipment supports neuro-electrophysiology research generating scientific breakthroughs on many fronts including in Alzheimer's disease, Parkinson's disease, addiction, and paralysis. Plexon is trusted worldwide for its legendary commitment to quality and customer partnership.







Media Contact:
Crystal Coco
Plexon Inc
Phone +1 (214) 369-4957 ext. 5298
Fax +1 (214) 369-1775

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Interface Financial Group Offers Invoice Factoring for SMEs Reluctant to Hire Staff xMatters Joins the Fight Against Prostate Cancer
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 10.11.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 86327
Anzahl Zeichen: 0

contact information:
Town:

DALLAS, TX



Kategorie:

Software



Diese Pressemitteilung wurde bisher 214 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Plexon Inc Launches the New Optogenetic Stimulation System at Neuroscience 2011"
steht unter der journalistisch-redaktionellen Verantwortung von

Plexon Inc (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Plexon Inc



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z